InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AtaiBeckley Inc.

ATAI Clue Score47
United States Fiscal year ends December CIK 0002081043
$7.35 +0.00% Close, 11 Sep 2026
Alert on the numbers Alert on insider trades
Price $7.35 −52.98% Close, 11 Sep 2026

Closing prices at the end of each trading day, from 18 Jun 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue0.3Operating income−102.7Net income−149.3EPS, diluted−0.93Fiscal year 2025Revenue4.1 +1,227.6%Operating income−644.1Net income−660.0EPS, diluted−2.91
FY2024FY2025
Revenue 0.3 4.1
Growth +1,227.6%
Operating income −102.7 −644.1
Net income −149.3 −660.0
Growth
EPS, diluted −0.93 −2.91
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2024Operating margin−33,341.2%Net margin−48,464.0%Free cash flow margin−26,767.2%Fiscal year 2025Operating margin−15,751.1%Net margin−16,142.0%Free cash flow margin−2,533.0%
FY2024FY2025
Operating margin −33,341.2% −15,751.1%
Net margin −48,464.0% −16,142.0%
Free cash flow margin −26,767.2% −2,533.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow−82.4Capital expenditure−0.0Free cash flow−82.4Fiscal year 2025Operating cash flow−102.7Capital expenditure−0.9Free cash flow−103.6
FY2024FY2025
Operating cash flow −82.4 −102.7
Capital expenditure −0.0 −0.9
Free cash flow −82.4 −103.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2024Cash17.5Total debt20.5Net cash (debt)−3.0Shareholders’ equity116.3Debt to equity0.18Fiscal year 2025Cash85.3Total debt0.0Net cash (debt)85.3Shareholders’ equity221.9Debt to equity0.00
FY2024FY2025
Cash 17.5 85.3
Total debt 20.5 0.0
Net cash (debt) −3.0 85.3
Shareholders’ equity 116.3 221.9
Debt to equity 0.18 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.3 4.1
Growth +1,227.6%
0.9 n/a
47.5 65.1
−102.7 −644.1
Growth
−148.4 −659.8
−0.4 0.3
−149.3 −660.0
Growth
Per share
−0.93 −2.91
−0.93 −2.91
Growth
160.2 226.5
160.2 226.5
Growth +41.4%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 2 years on file.